0001628280-22-018767.txt : 20220711
0001628280-22-018767.hdr.sgml : 20220711
20220711061631
ACCESSION NUMBER: 0001628280-22-018767
CONFORMED SUBMISSION TYPE: 4/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220518
FILED AS OF DATE: 20220711
DATE AS OF CHANGE: 20220711
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Jayne David R.W.
CENTRAL INDEX KEY: 0001838242
FILING VALUES:
FORM TYPE: 4/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36421
FILM NUMBER: 221075840
MAIL ADDRESS:
STREET 1: #1203-4464 MARKHAM STREET
CITY: VICTORIA
STATE: A1
ZIP: BC V8Z7X8
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Aurinia Pharmaceuticals Inc.
CENTRAL INDEX KEY: 0001600620
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: A0
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: #1203-4464 MARKHAM STREET
CITY: VICTORIA BC
STATE: A1
ZIP: V8Z 7X8
BUSINESS PHONE: 250-708-4272
MAIL ADDRESS:
STREET 1: #1203-4464 MARKHAM STREET
CITY: VICTORIA BC
STATE: A1
ZIP: V8Z 7X8
4/A
1
wf-form4a_165753457810786.xml
FORM 4/A
X0306
4/A
2022-05-18
2022-05-20
0
0001600620
Aurinia Pharmaceuticals Inc.
AUPH
0001838242
Jayne David R.W.
#1203-4464 MARKHAM STREET
VICTORIA
A1
V8Z7X8
BRITISH COLUMBIA, CANADA
1
0
0
0
Common Stock
2022-05-18
4
M
0
10000
3.62
A
40000
D
Stock Option (right to buy)
3.62
2022-05-18
4
M
0
10000
0
D
2027-02-16
Common Stock
10000.0
0
D
Converted to U.S. dollars based on the average daily exchange rate of the Bank of Canada reported on the grant date.
The shares subject to the option are fully vested and immediately exercisable. They vested in twelve equal monthly installments from the grant date.
This amendment is filed to correct the inadvertent omission of the option exercise transaction from the Reporting Person's Form 4 filed on May 20, 2022.
/s/ David R.W. Jayne, M.D.
2022-07-08